Company Filing History:
2 out of 1,697 
1 out of 7 
1 out of 832,912 Years Active: 1999-2006
Title: Wilfried Ellmeier: Innovator in HIV Research
Introduction
Wilfried Ellmeier is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of HIV research. He holds a total of 3 patents, which focus on methods related to the identification of g-coupled receptors associated with macrophage-trophic HIV. His work has been instrumental in advancing our understanding of HIV entry mechanisms and potential therapeutic approaches.
Latest Patents
Ellmeier's latest patents include innovative methods for identifying g-coupled receptors that play a crucial role in the entry of HIV-1 into target cells. His research highlights that the entry of HIV-1 requires not only the cell surface CD4 but also additional host cell cofactors. One of the key findings is the identification of CC-CKR5 as the principal cofactor for entry mediated by the envelope glycoproteins of primary macrophage-tropic strains of HIV-1. This receptor is associated with the β-chemokines RANTES, MIP-1α, and MIP-1β, which are vital for understanding the pathogenic strains of HIV in vivo.
Career Highlights
Throughout his career, Wilfried Ellmeier has worked with esteemed institutions such as New York University and the Aaron Diamond AIDS Research Center. His research has significantly impacted the scientific community's approach to HIV treatment and prevention.
Collaborations
Ellmeier has collaborated with notable scientists, including Dan R. Littman and Hongkui Deng, further enhancing the depth and breadth of his research contributions.
Conclusion
Wilfried Ellmeier's innovative work in HIV research and his patented methods for identifying critical receptors have made a lasting impact on the field. His contributions continue to pave the way for advancements in diagnostic and therapeutic strategies against HIV.